NGAL Fast Test Kit - India CDSCO Medical Device Registration

NGAL Fast Test Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000410_9a64ec8af3f49647af09620ee119eb45_fb47adfc312afbe0af9e355423cd6060. This device is marketed under the brand name Imumunofluorescence Assay. The license holder is Vector Biotek Pvt Ltd, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class B

NGAL Fast Test Kit

UID: IMP/IVD/2019/000410_9a64ec8af3f49647af09620ee119eb45_fb47adfc312afbe0af9e355423cd6060

Brand Name

Imumunofluorescence Assay

License Holder

Vector Biotek Pvt Ltd

Device Class

Class B

Approving Authority

CDSCO

Product Information

NGAL Fast Test Kit (Imumunofluorescence Assay) is intended for in vitro quantitative determination of neutrophils gelatinase associated lipocalin (Imumunofluorescence Assay) in serum and urine. This test is used as an aid in the early diagnosis of acute kidney injury (Imumunofluorescence Assay), risk classification and treatment monitoring